In the BioHarmony Drug Report Database
Zosyn, Zerbaxa (tazobactam) is a small molecule pharmaceutical. Tazobactam was first approved as Zosyn on 1993-10-22. It has been approved in Europe to treat bacterial infections. Zosyn in galaxy containers’s patent is valid until 2023-04-14 (FDA).
Image (chem structure or protein)